Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin
Publication date
2020-01-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Diphtheria toxoid is produced by detoxification of diphtheria toxin with formaldehyde. This study was performed to elucidate the chemical nature and location of formaldehyde-induced modifications in diphtheria toxoid. Diphtheria toxin was chemically modified using 4 different reactions with the following reagents: (1) formaldehyde and NaCNBH3, (2) formaldehyde, (3) formaldehyde and NaCNBH3 followed by formaldehyde and glycine, and (4) formaldehyde and glycine. The modifications were studied by SDS-PAGE, primary amino group determination, and liquid chromatography–electrospray mass spectrometry of chymotryptic digests. Reaction 1 resulted in quantitative dimethylation of all lysine residues. Reaction 2 caused intramolecular cross-links, including the NAD+-binding cavity and the receptor-binding site. Moreover, A fragments and B fragments were cross-linked by formaldehyde on part of the diphtheria toxoid molecules. Reaction 3 resulted in formaldehyde-glycine attachments, including in shielded areas of the protein. The detoxification reaction typically used for vaccine preparation (reaction 4) resulted in a combination of intramolecular cross-links and formaldehyde-glycine attachments. Both the NAD+-binding cavity and the receptor-binding site of diphtheria toxin were chemically modified. Although CD4+ T-cell epitopes were affected to some extent, one universal CD4+ T-cell epitope remained almost completely unaltered by the treatment with formaldehyde and glycine.
Keywords
chemical modification, diphtheria toxoid, formaldehyde, mass spectrometry, vaccine, Pharmaceutical Science, SDG 3 - Good Health and Well-being
Citation
Metz, B, Michiels, T, Uittenbogaard, J, Danial, M, Tilstra, W, Meiring, H D, Hennink, W E, Crommelin, D J A, Kersten, G F A & Jiskoot, W 2020, 'Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin', Journal of Pharmaceutical Sciences, vol. 109, no. 1, pp. 543-557. https://doi.org/10.1016/j.xphs.2019.10.047